Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prospective Open Label Clinical and Genetic Testing of Patients With Usher Syndrome

NCT03319524 is registered in ClinicalTrials.gov with Sensor Technology for Deafblind as lead sponsor.

NCT NCT03319524
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03319524 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prospective Open Label Clinical and Genetic Testing of Patients With Usher Syndrome
Lead sponsor
Sensor Technology for Deafblind
Phase
Observational
Overall status
Completed
Start date
May 17, 2017
Completion date
June 1, 2018
Enrollment
28 (actual)
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

congenital deafness, retinitis pigmentosa, usher syndrome